NSP-5033

N/A

Report date: 2024/05/17 15:47:53

Base Information

Drug NameNSP-5033
Drug Alias NameNSP-5033
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTCDD-inducible poly [ADP-ribose] polymerase inhibitors
TargetsTCDD-inducible poly [ADP-ribose] polymerase
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusIND
Highest Status in ChinaIND
Originator CompaniesNovostar Pharmaceuticals Ltd
China Registration ClassN/A

Develop Information

Active CompaniesNovostar Pharmaceuticals Ltd
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A